DE13731071T1 - Verfahren zur Quantifizierung von Immunzellen in Tumorgewebe und dessen Anwendungen - Google Patents

Verfahren zur Quantifizierung von Immunzellen in Tumorgewebe und dessen Anwendungen Download PDF

Info

Publication number
DE13731071T1
DE13731071T1 DE13731071.0T DE13731071T DE13731071T1 DE 13731071 T1 DE13731071 T1 DE 13731071T1 DE 13731071 T DE13731071 T DE 13731071T DE 13731071 T1 DE13731071 T1 DE 13731071T1
Authority
DE
Germany
Prior art keywords
stained cells
cells
tumor
stained
cd45ro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE13731071.0T
Other languages
German (de)
English (en)
Inventor
Jérôme GALON
Bernhard Mlecnik
Franck PAGÈS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé et de la Recherche Médicale
Université Paris Descartes
Original Assignee
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé et de la Recherche Médicale
Université Paris Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique - Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale, Université Paris Descartes filed Critical Assistance Publique - Hôpitaux de Paris
Publication of DE13731071T1 publication Critical patent/DE13731071T1/de
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE13731071.0T 2012-06-14 2013-06-14 Verfahren zur Quantifizierung von Immunzellen in Tumorgewebe und dessen Anwendungen Pending DE13731071T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IB2012001446 2012-06-14
WOPCT/IB2012/001446 2012-06-14
PCT/EP2013/062405 WO2013186374A1 (en) 2012-06-14 2013-06-14 Method for quantifying immune cells in tumoral tissues and its applications
EP13731071.0A EP2861986B1 (en) 2012-06-14 2013-06-14 Method for quantifying immune cells in tumoral tissues and its applications

Publications (1)

Publication Number Publication Date
DE13731071T1 true DE13731071T1 (de) 2016-08-18

Family

ID=46881097

Family Applications (1)

Application Number Title Priority Date Filing Date
DE13731071.0T Pending DE13731071T1 (de) 2012-06-14 2013-06-14 Verfahren zur Quantifizierung von Immunzellen in Tumorgewebe und dessen Anwendungen

Country Status (13)

Country Link
US (1) US10317408B2 (cg-RX-API-DMAC10.html)
EP (1) EP2861986B1 (cg-RX-API-DMAC10.html)
JP (1) JP6449765B2 (cg-RX-API-DMAC10.html)
KR (1) KR102179848B1 (cg-RX-API-DMAC10.html)
CN (1) CN104541167B (cg-RX-API-DMAC10.html)
AU (1) AU2013276470B2 (cg-RX-API-DMAC10.html)
BR (1) BR112014031143B8 (cg-RX-API-DMAC10.html)
CA (1) CA2873278C (cg-RX-API-DMAC10.html)
DE (1) DE13731071T1 (cg-RX-API-DMAC10.html)
ES (1) ES2902879T3 (cg-RX-API-DMAC10.html)
IL (1) IL235738B (cg-RX-API-DMAC10.html)
SG (1) SG11201408107RA (cg-RX-API-DMAC10.html)
WO (1) WO2013186374A1 (cg-RX-API-DMAC10.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6605506B2 (ja) 2014-02-24 2019-11-13 ヴェンタナ メディカル システムズ, インク. CD3、CD8、CD20及びFoxP3の同時検出によりがんに対する免疫応答をスコア化するための方法、キット、及びシステム
JP6802153B2 (ja) * 2014-09-03 2020-12-16 ヴェンタナ メディカル システムズ, インク. 免疫スコアを計算するためのシステム及び方法
WO2016073760A1 (en) * 2014-11-05 2016-05-12 The Regents Of The University Of California Methods for stratifying non-responders to therapies that block pd1/pdl1 axis
US10034901B2 (en) 2015-01-22 2018-07-31 University Of Massachusetts Cancer immunotherapy
CN113671186A (zh) * 2015-10-23 2021-11-19 诺华股份有限公司 对包含肿瘤组织的样品评分的方法
JP7281903B2 (ja) * 2016-05-09 2023-05-26 アンセルム(アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル) 固形腫瘍を有する患者をクラス分けするための方法
EP3459046B1 (en) * 2016-05-18 2021-06-16 F. Hoffmann-La Roche AG Tumor proximity measure
WO2018027223A1 (en) * 2016-08-05 2018-02-08 Duke University Camkk2 inhibitor compositions and methods of using the same
EP3532984B1 (en) * 2016-10-27 2024-05-08 Koninklijke Philips N.V. Apparatus for determining cellular composition information in one or more tissue samples
WO2018081817A2 (en) 2016-10-31 2018-05-03 University Of Massachusetts Targeting microrna-101-3p in cancer therapy
CN106846310A (zh) * 2017-01-19 2017-06-13 宁波江丰生物信息技术有限公司 一种基于免疫组化技术的病理辅助分析方法
WO2019020556A1 (en) * 2017-07-24 2019-01-31 Ventana Medical Systems, Inc. METHODS AND SYSTEMS FOR ASSESSING INFILTRAT OF IMMUNE CELLS IN TUMOR SAMPLES
CA3089562A1 (en) 2018-01-30 2019-08-08 University Of Massachusetts Methods of treating a wound using epigenetic regulation
WO2019149817A1 (en) 2018-01-31 2019-08-08 Ventana Medical Systems, Inc. Methods and systems for evaluation of immune cell infiltrate in stage iii colorectal cancer
WO2020161125A1 (en) * 2019-02-05 2020-08-13 Ventana Medical Systems, Inc. Methods and systems for evaluation of immune cell infiltrate in stage iv colorectal cancer
CN114072676B (zh) 2019-06-03 2024-07-12 法国国家卫生及研究医学协会 调节治疗方案的方法
WO2021092071A1 (en) 2019-11-07 2021-05-14 Oncxerna Therapeutics, Inc. Classification of tumor microenvironments
CN111551546B (zh) * 2020-06-01 2023-01-03 南京瑟斯检测科技有限公司 一种基于光学微腔结构超材料的免疫组化便捷检测方法
EP4172621A1 (en) 2020-06-30 2023-05-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting the risk of recurrence and/or death of patients suffering from a solid cancer after preoperative adjuvant therapies
JP7741831B2 (ja) * 2020-06-30 2025-09-18 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 術前補助療法及び根治手術後の固形がんを患っている患者の再発及び/又は死亡のリスクを予測するための方法
TWI838687B (zh) * 2021-01-30 2024-04-11 奇美醫療財團法人奇美醫院 評估腫瘤標本免疫狀態的方法
CN113092202A (zh) * 2021-03-25 2021-07-09 上海福君基因生物科技有限公司 一种胃癌预后预测装置
CN113515077A (zh) * 2021-04-23 2021-10-19 重庆德方信息技术有限公司 人体细胞染色过程监控系统及方法
WO2023018085A1 (ko) * 2021-08-10 2023-02-16 주식회사 루닛 병리 슬라이드 이미지와 관련된 정보를 출력하는 방법 및 장치
CN114494155B (zh) * 2021-12-31 2026-07-28 广东省人民医院 非小细胞肺癌ihc染色图像肿瘤区域免疫分级方法、系统及存储介质
US20250035635A1 (en) 2022-03-17 2025-01-30 Institut National De La Sante Et De La Recherche Medicale Methods for predicting response to an immunotherapeutic treatment in a patient with a cancer
TW202440636A (zh) 2023-03-21 2024-10-16 美商傳記55有限公司 Cd19/cd38多特異性抗體
US12700249B2 (en) * 2023-07-06 2026-08-04 Pictor Labs, Inc. Systems and methods for training machine learning on noisy and inaccurate immunostains
CN116646088B (zh) * 2023-07-27 2023-12-01 广东省人民医院 一种预测方法、装置、设备及介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020198A2 (en) * 1995-11-30 1997-06-05 Chromavision Medical Systems, Inc. Method and apparatus for automated image analysis of biological specimens
EP1777523A1 (en) * 2005-10-19 2007-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
JP4933563B2 (ja) * 2005-12-19 2012-05-16 ヴェンタナ メディカル システムズ, インコーポレイテッド 解剖病理学における自動リーンメソッド
CN102165489B (zh) * 2008-09-16 2015-11-25 赫斯托克斯公司 生物标志物表达的可再现量化
FR2964744B1 (fr) * 2010-09-10 2015-04-03 Univ Versailles St Quentin En Yvelines Test pronostic de l'evolution d'une tumeur solide par analyse d'images

Also Published As

Publication number Publication date
JP2015525349A (ja) 2015-09-03
CN104541167A (zh) 2015-04-22
CA2873278A1 (en) 2013-12-19
ES2902879T3 (es) 2022-03-30
JP6449765B2 (ja) 2019-01-09
CN104541167B (zh) 2018-05-01
BR112014031143B1 (pt) 2022-03-03
EP2861986A1 (en) 2015-04-22
IL235738B (en) 2019-02-28
KR102179848B1 (ko) 2020-11-17
SG11201408107RA (en) 2015-01-29
WO2013186374A1 (en) 2013-12-19
AU2013276470A1 (en) 2014-11-27
KR20150023760A (ko) 2015-03-05
EP2861986B1 (en) 2021-11-10
IL235738A0 (en) 2015-01-29
US10317408B2 (en) 2019-06-11
BR112014031143B8 (pt) 2022-11-22
US20150153349A1 (en) 2015-06-04
AU2013276470B2 (en) 2018-06-07
BR112014031143A2 (pt) 2017-08-08
CA2873278C (en) 2021-10-26

Similar Documents

Publication Publication Date Title
JP2015525349A5 (cg-RX-API-DMAC10.html)
CN109285222A (zh) 有机页岩高分辨率数字岩心构建与分析方法
DE102011004598A1 (de) Verfahren und Computersystem zur Streustrahlkorrektur in einem Multi-Source-CT
DE102013224310A1 (de) Verfahren und System zum Erhöhen eines dynamischen Nutzbereichs einer Spektrometrievorrichtung
DE102010004384A1 (de) Verfahren zur Ermittlung von der Berechnung eines Bestrahlungsplans zugrunde zu legenden Informationen und kombinierte Magnetresonanz-PET-Vorrichtung
Ramos-Munoz et al. Middle Palaeolithic Mode 3 lithic technology in the rock-shelter of Benzú (North Africa) and its immediate environmental relationships
Puškaš et al. Fractal dimension of apical dendritic arborization differs in the superficial and the deep pyramidal neurons of the rat cerebral neocortex
DE112012002671T5 (de) Anzeigen einer Vielzahl von registrierten Bildern
DE102014200303A1 (de) Verfahren zur Durchführung einer Positronenemissionstomographie
Chen et al. Quantitative 3D structural analysis of the cellular microstructure of sea urchin spines (II): Large-volume structural analysis
DE102022000957A1 (de) Baueinheiten für maschinelle lernmodelle zum entrauschen von bildern, sowie systeme und verfahren zu deren verwendung
DE102014208411A1 (de) Auswertung eines während einer Mammographie erzeugten Röntgenbildes einer Brust
Martínez et al. Lacunarity of soil macropore space arrangement of CT images: effect of soil management and depth
DE102017221924B3 (de) Verfahren zur Fusionierung eines Analysedatensatzes mit einem Bilddatensatz, Positionierungseinrichtung und Computerprogramm
DE102015206630B4 (de) Multispektrale CT-Bildgebung
Sultan et al. A segmentation-free machine learning architecture for immune land-scape phenotyping in solid tumors by multichannel imaging
Martinez-Perez et al. There is no general model for occlusal kinematics in conodonts
DE112018006190T5 (de) Subtypisierung von tnbc und methoden
DE102015215778B4 (de) Verfahren zu einer Darstellung von Magnetresonanz-Daten
Heiny Socio-economic conditions of rural Georgian households and their behavioral intentions regarding tourism development: an empirical analysis
DE102015203537B3 (de) Vorrichtung und Verfahren zur Überprüfung eines Materials für eine Transplantation
Kalkan et al. Preliminary investigations on crustaceans associated with the Mediterranean mussel (Mytilus galloprovincialis Lamarck, 1819) beds in the upper infralittoral of the Bosphorus (Turkey)
EP2793188A3 (de) Verfahren und System zur Verarbeitung von MRT-Daten des menschlichen Gehirns
DE202013103215U1 (de) Ein geführtes Scheibenschneidsystem zum Erhalten von histologischen Proben
DE102008036814A1 (de) Klassifizierungsverfahren und Klassifizierungseinheit für Objektgruppen und/oder Gewebemerkmalsgruppen sowie Verfahren zur Ermittlung von Entwicklungsdaten